Your browser doesn't support javascript.
loading
Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
Cao, Xiting; Ejzykowicz, Flavia; Ramey, Dena R; Sajjan, Shiva; Ambegaonkar, Baishali M; Mavros, Panagiotis; Tunceli, Kaan.
Afiliação
  • Cao X; Merck & Co, Inc, Whitehouse Station, New Jersey. Electronic address: xiting.cao@merck.com.
  • Ejzykowicz F; Merck & Co, Inc, Whitehouse Station, New Jersey.
  • Ramey DR; Merck & Co, Inc, Whitehouse Station, New Jersey.
  • Sajjan S; Merck & Co, Inc, Whitehouse Station, New Jersey.
  • Ambegaonkar BM; Merck & Co, Inc, Whitehouse Station, New Jersey.
  • Mavros P; Merck & Co, Inc, Whitehouse Station, New Jersey.
  • Tunceli K; Merck & Co, Inc, Whitehouse Station, New Jersey.
Clin Ther ; 37(4): 804-15, 2015 Apr 01.
Article em En | MEDLINE | ID: mdl-25626487
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Sinvastatina / Ezetimiba / Hipercolesterolemia Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Sinvastatina / Ezetimiba / Hipercolesterolemia Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article